TrialArthritis & rheumatology (Hoboken, N.J.)2017

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.

William Stohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.